Active substance

Results for the substance panobinostat

3 results

About this active substance

Panobinostat is a histone deacetylase inhibitor used in the treatment of relapsed or refractory multiple myeloma. It works by altering gene expression and inhibiting tumor cell growth.

The medication is administered orally, as directed by a doctor, usually three times a week in treatment cycles. It is important for patients to follow the treatment regimen and undergo regular tests to monitor the therapy's effects.

Patients should be aware of potential side effects, such as diarrhea, nausea, or fatigue. It is important to inform the doctor of any unusual symptoms.

Common side effects include diarrhea, nausea, and fatigue. In rare cases, severe reactions such as hematologic toxicity or cardiac arrhythmias may occur. Patients should be informed of these risks before use.